Home > Pain Relief > Masimo Bridge - Drug-Free Opioid Withdrawal Device
	Price: $695.00 Product Code: MAS-4790 NOT AVAILABLE Email me when Back-In-Stock

Description   Bridge is the first FDA-cleared, drug-free, non-surgical device to use neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. Bridge is a small electrical nerve stimulator device that contains a battery-powered chip and wires that are applied around a patient's ear. It requires a prescription and is offered to qualified healthcare professionals with training. The Bridge kit includes everything needed to apply the device. FAST — Provides symptom relief beginning in as little as 20 minutes 1 EFFECTIVE — May significantly reduce opioid withdrawal symptoms Help users successfully progress in treatment 88% of patients successfully transitioned into a medically assisted therapy (MAT) program1 SAFE2 — No reported side effects with minimal risks during device placement 0.17% Incidence of significant pain at the lead implantation site 0.91% Incidence of bleeding at the lead implantation site 0.91% Incidence of dermatitis at the lead implantation site 0% Incidence of syncope Who Can Bridge Help? Bridge can be used for patients* experiencing opioid withdrawal symptoms, while undergoing treatment for opioid use disorder when: Initiating treatment Transitioning to naltrexone Tapering off medication-assisted treatment Click here to download the printable Masimo Bridge brochure References: *Contraindications: Use of cardiac pacemakers, Hemophilia, Psoriasis vulgaris 1Miranda A, Taca A. Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment [published correction appears in Am J Drug Alcohol Abuse. 2018;44(4):498]. Am J Drug Alcohol Abuse. 2018;44(1):56‐63. doi:10.1080/00952990.2017.1295459 2Roberts, Arthur et al. “Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study.” Medical devices (Auckland, N.Z.) vol. 9 389-393. 3 Nov. 2016, doi:10.2147/MDER.S107426Roberts, Arthur et al. “Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study.” Medical devices (Auckland, N.Z.) vol. 9 389-393. 3 Nov. 2016, doi:10.2147/MDER.S107426.

Share your knowledge with other customers... Be the first to write a review

Browse for more products in the same category as this item: Pain Relief